US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eisai Co., Ltd.

7.32

+0.11001.53%

Volume:211.06K

Turnover:1.53M

Market Cap:8.33B

PE:41.36

High:7.33

Open:7.30

Low:7.27

Close:7.21

52wk High:9.22

52wk Low:5.69

Shares:1.14B

Float Shares:1.08B

Volume Ratio:2.51

T/O Rate:0.02%

Dividend:0.24

Dividend Rate:3.34%

EPS(TTM):0.1770

EPS(LYR):0.2444

ROE:4.52%

ROA:1.95%

PB:1.52

PE(LYR):29.95

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Eisai, Biogen announce presentation of results from real-world LEADER study

Biogen, Eisai announce new data on efficacy, safety of LEQEMBI SC-AI

Eisai Sees Strong 2028 Sales Potential for BioArctic’s Alzheimer’s Drug Leqembi

Eisai, Biogen announce FDA extension of review period for lecanemab-irmb sBLA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ESAIY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESAIY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":7.32,"timestamp":1785268800000,"preClose":7.21,"halted":0,"volume":211060,"delay":15,"changeRate":0.015256588072122098,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"Pre-Mkt","change":0.11,"latestTime":"07-28 16:00:00 EDT Delay","open":7.295,"high":7.33,"low":7.2679,"amount":1530075.3388999996,"amplitude":0.008613,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785331800000},"marketStatusCode":1,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":7.32,"volumeRatio":2.5139119184013055},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","floatShares":1076747898,"roa":"1.95%","roe":"4.52%","lyrEps":0.244385,"volumeRatio":2.5139119184013055,"shares":1137465824,"dividePrice":0.24448,"high":7.33,"amplitude":0.008613,"preClose":7.21,"low":7.2679,"week52Low":5.6871,"pbRate":"1.52","psRate":"1.65","week52High":9.22,"institutionHeld":0,"latestPrice":7.32,"eps":0.176978,"divideRate":0.033399,"volume":211060,"delay":15,"ttmEps":0.176978,"open":7.295,"prevYearClose":7.38,"prevWeekClose":7.1,"prevMonthClose":6.27,"prevQuarterClose":6.27,"fiveDayClose":6.88,"twentyDayClose":6.37,"sixtyDayClose":7.49,"earningDate":1785686400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESAIY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-02-06","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":null},{"date":"2024-08-01","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722542400000,"name":null,"time":"Post Market","dateTimestamp":1722484800000,"actualEps":null},{"date":"2024-05-14","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715716800000,"name":null,"time":"Post Market","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESAIY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESAIY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.125,"hold":0.6875,"sell":0.0625,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6875,"analysts":16,"updateTime":1783569600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESAIY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651010742","title":"Eisai, Biogen announce presentation of results from real-world LEADER study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651010742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651010742?lang=en_us&edition=fundamental","pubTime":"2026-07-14 23:25","pubTimestamp":1784042718,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that results from the real-world Lecanemab in Early Alzheimer’s Disease Study show that nearly 83% of ear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-presentation-of-results-from-real-world-leader-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-presentation-of-results-from-real-world-leader-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4007","BK4532","IE00B894F039.SGD","LU0320765992.SGD","BK4139","ESAIY","BK4533","BIIB","IE00B19Z9Z06.USD","LU0234570918.USD","IE00B19Z9P08.USD","PBE","BMED","BK4585","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651216568","title":"Biogen, Eisai announce new data on efficacy, safety of LEQEMBI SC-AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2651216568","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651216568?lang=en_us&edition=fundamental","pubTime":"2026-07-12 23:50","pubTimestamp":1783871406,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that new data presented at the Alzheimer’s Association International Conference, AAIC, 2026 in London sup...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-new-data-on-efficacy-safety-of-leqembi-sc-ai-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-new-data-on-efficacy-safety-of-leqembi-sc-ai-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0234570918.USD","VTHR","AIPO","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4585","LU0109394709.USD","ESAIY","LU0320765992.SGD","AGIX","QTOC","BIIB","BK4532","BK4139","PBE","ARTY","BMED","IE00B894F039.SGD","CHAT","BK4588","LU0889565916.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638790533","title":"Eisai Sees Strong 2028 Sales Potential for BioArctic’s Alzheimer’s Drug Leqembi","url":"https://stock-news.laohu8.com/highlight/detail?id=2638790533","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638790533?lang=en_us&edition=fundamental","pubTime":"2026-05-25 15:32","pubTimestamp":1779694364,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has provided an announcement. BioArctic’s partner Eisai has published a sales simulation suggesting that Alzh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eisai-sees-strong-2028-sales-potential-for-bioarctics-alzheimers-drug-leqembi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eisai-sees-strong-2028-sales-potential-for-bioarctics-alzheimers-drug-leqembi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ESAIY","BK4139","BRCTF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633396524","title":"Eisai, Biogen announce FDA extension of review period for lecanemab-irmb sBLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2633396524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633396524?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:20","pubTimestamp":1778232059,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that the FDA has extended the review period by three months for the supplemental biologics license applic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-fda-extension-of-review-period-for-lecanemab-irmb-sbla-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-fda-extension-of-review-period-for-lecanemab-irmb-sbla-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4532","ESAIY","BK4007","LU0320765992.SGD","LU0889565916.HKD","LABU","BK4139","BIIB","IE00B19Z9P08.USD","BK4585","BK4588","IE00B19Z9Z06.USD","BK4533","IE00B894F039.SGD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ESAIY\",params:#limit:6,delay:false,,,undefined,":[]}}